logologologo
  • Home
  • About
  • Investors
  • News
  • Contact Us
logologologo
  • Home
  • About
  • Investors
  • News
  • Contact Us
logologologo
  • Home
  • About
  • Investors
  • News
  • Contact Us
  • Home
  • About
  • Investors
  • News
  • Contact Us

Our Team Is Our Advantage

Very few people truly understand the cannabis industry. Our team has decades of experience in the pre rec-legal industry and it makes a difference.

Unlike many companies rushing into cannabis, through our experience and relationships, we are able to see opportunities others don’t.

COME GROW WITH US

GET IN TOUCH
Play Video
Play Video
Play Video
PRESIDENT’S MESSAGE

“We are at a historical turning point – the end of a prohibition.”

KARL KOTTMEIER

Very rarely, maybe once in a life time will anyone get an opportunity like this. The epicentre of this opportunity is California and Chemistree has already established itself as a multifaceted player in that market.

Come join us in this growth story.

GET IN TOUCH
TURN AROUND STORY

Sugarleaf Case Study

We identify, re-organize and properly capitalize opportunities for sustainable growth. Read our case study on the turn around of Sugarleaf in Washington State.

LEARN MORE
LATEST NEWS
August 5, 2020

Chemistree Completes Expansion of Sugarleaf Facility

Washington State operation grows by about 30% VANCOUVER, BC, Aug. 5, 2020 /PRNewswire/...
July 9, 2020

Chemistree Closes First Tranche of ImmunoFlex Investment

Vancouver, British Columbia, July 9, 2020– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US...
June 18, 2020

Chemistree Details Immunoflex Investment

Cannabinoid-Linked, Immunology and Virology focused Biotech Venture VANCOUVER, BC, June 18,...
August 5, 2020

Chemistree Completes Expansion of Sugarleaf Facility

Washington State operation grows by about 30% VANCOUVER, BC, Aug. 5, 2020 /PRNewswire/...
July 9, 2020

Chemistree Closes First Tranche of ImmunoFlex Investment

Vancouver, British Columbia, July 9, 2020– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US...
June 18, 2020

Chemistree Details Immunoflex Investment

Cannabinoid-Linked, Immunology and Virology focused Biotech Venture VANCOUVER, BC, June 18,...
MORE NEWS

Our Team, Our Advantage

Team Chemistree

We are proud to bring together a team of career cannabis experts. Click below to learn more and connect with us.

ABOUT US

Karl Kottmeier

President and CEO

Sheldon Aberman

Chief Cannabis Officer and Director

Doug Ford

Chief Financial Officer

Significant Developments

Our Timeline

July 2018

Completion of $4.5 million financing
Dec 2018

Enter into an agreement with Sugarleaf Farms to acquire the global brand and marketing rights to the Sugarleaf brand (outside of Washington State)
Apr 2019

Completion of $10,830,000 debenture financing
Jun 2019

Investment completed in Applied Cannabis Sciences Partnership. Filed three applications in New Jersey
Jun 2020

Agreement to invest up to $1 million in Immunoflex biotech venture

Corporate Presentation

Industry Knowledge

Chemistree is a public entity for investors looking to participate in a US focused, vertically integrated operation.

DOWNLOAD

Come Grow With Us

GET IN TOUCH

#204 – 998 Harbourside Drive North Vancouver, BC V7P 3T2

Facebook Twitter Instagram

Privacy Policy

© 2019 Chemistree Technology Inc. All rights reserved.